Literature DB >> 23592718

Structural basis for angiopoietin-1-mediated signaling initiation.

Xuehong Yu1, Tom C M Seegar, Annamarie C Dalton, Dorothea Tzvetkova-Robev, Yehuda Goldgur, Kanagalaghatta R Rajashankar, Dimitar B Nikolov, William A Barton.   

Abstract

Angiogenesis is a complex cellular process involving multiple regulatory growth factors and growth factor receptors. Among them, the ligands for the endothelial-specific tunica intima endothelial receptor tyrosine kinase 2 (Tie2) receptor kinase, angiopoietin-1 (Ang1) and Ang2, play essential roles in balancing vessel stability and regression during both developmental and tumor-induced angiogenesis. Despite possessing a high degree of sequence identity, Ang1 and Ang2 have distinct functional roles and cell-signaling characteristics. Here, we present the crystal structures of Ang1 both unbound and in complex with the Tie2 ectodomain. Comparison of the Ang1-containing structures with their Ang2-containing counterparts provide insight into the mechanism of receptor activation and reveal molecular surfaces important for interactions with Tie2 coreceptors and associated signaling proteins. Using structure-based mutagenesis, we identify a loop within the angiopoietin P domain, adjacent to the receptor-binding interface, which confers the specific agonist/antagonist properties of the molecule. We demonstrate using cell-based assays that an Ang2 chimera containing the Ang1 loop sequence behaves functionally similarly to Ang1 as a constitutive Tie2 agonist, able to efficiently dissociate the inhibitory Tie1/Tie2 complex and elicit Tie2 clustering and downstream signaling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23592718      PMCID: PMC3645508          DOI: 10.1073/pnas.1216890110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

Review 1.  Tie receptors: new modulators of angiogenic and lymphangiogenic responses.

Authors:  N Jones; K Iljin; D J Dumont; K Alitalo
Journal:  Nat Rev Mol Cell Biol       Date:  2001-04       Impact factor: 94.444

2.  Implementation of molecular replacement in AMoRe.

Authors:  J Navaza
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-09-21

Review 3.  Vascular-specific growth factors and blood vessel formation.

Authors:  G D Yancopoulos; S Davis; N W Gale; J S Rudge; S J Wiegand; J Holash
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

4.  Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering.

Authors:  Samuel Davis; Nick Papadopoulos; Thomas H Aldrich; Peter C Maisonpierre; Tammy Huang; Lubomir Kovac; April Xu; Raymond Leidich; Elzbieta Radziejewska; Ashique Rafique; Judah Goldberg; Vivek Jain; Kevin Bailey; Margaret Karow; Jim Fandl; Steven J Samuelsson; Ella Ioffe; John S Rudge; Thomas J Daly; Czeslaw Radziejewski; George D Yancopoulos
Journal:  Nat Struct Biol       Date:  2003-01

Review 5.  Vascular development: molecular logic for defining arteries and veins.

Authors:  Thomas N Sato
Journal:  Curr Opin Hematol       Date:  2003-03       Impact factor: 3.284

6.  Direct incorporation of experimental phase information in model refinement.

Authors:  Pavol Skubák; Garib N Murshudov; Navraj S Pannu
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

7.  Angiopoietins 3 and 4: diverging gene counterparts in mice and humans.

Authors:  D M Valenzuela; J A Griffiths; J Rojas; T H Aldrich; P F Jones; H Zhou; J McClain; N G Copeland; D J Gilbert; N A Jenkins; T Huang; N Papadopoulos; P C Maisonpierre; S Davis; G D Yancopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

8.  Structure of the angiopoietin-2 receptor binding domain and identification of surfaces involved in Tie2 recognition.

Authors:  William A Barton; Dorothea Tzvetkova; Dimitar B Nikolov
Journal:  Structure       Date:  2005-05       Impact factor: 5.006

9.  Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway.

Authors:  Laura M DeBusk; Dennis E Hallahan; Pengnian Charles Lin
Journal:  Exp Cell Res       Date:  2004-08-01       Impact factor: 3.905

Review 10.  Angiogenesis in ischemic and neoplastic disorders.

Authors:  Gregg L Semenza
Journal:  Annu Rev Med       Date:  2001-12-03       Impact factor: 13.739

View more
  31 in total

1.  The angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammation.

Authors:  Katelyn E Milam; Samir M Parikh
Journal:  Tissue Barriers       Date:  2015-04-03

2.  Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity.

Authors:  Tomokazu Souma; Stuart W Tompson; Benjamin R Thomson; Owen M Siggs; Krishnakumar Kizhatil; Shinji Yamaguchi; Liang Feng; Vachiranee Limviphuvadh; Kristina N Whisenhunt; Sebastian Maurer-Stroh; Tammy L Yanovitch; Luba Kalaydjieva; Dimitar N Azmanov; Simone Finzi; Lucia Mauri; Shahrbanou Javadiyan; Emmanuelle Souzeau; Tiger Zhou; Alex W Hewitt; Bethany Kloss; Kathryn P Burdon; David A Mackey; Keri F Allen; Jonathan B Ruddle; Sing-Hui Lim; Steve Rozen; Khanh-Nhat Tran-Viet; Xiaorong Liu; Simon John; Janey L Wiggs; Francesca Pasutto; Jamie E Craig; Jing Jin; Susan E Quaggin; Terri L Young
Journal:  J Clin Invest       Date:  2016-06-06       Impact factor: 14.808

3.  Dimerization of Tie2 mediated by its membrane-proximal FNIII domains.

Authors:  Jason O Moore; Mark A Lemmon; Kathryn M Ferguson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-10       Impact factor: 11.205

Review 4.  The Angiopoietin-Tie2 Signaling Axis in Systemic Inflammation.

Authors:  Samir M Parikh
Journal:  J Am Soc Nephrol       Date:  2017-05-02       Impact factor: 10.121

5.  A collagen IV-derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling.

Authors:  Adam C Mirando; Jikui Shen; Raquel Lima E Silva; Zenny Chu; Nicholas C Sass; Valeria E Lorenc; Jordan J Green; Peter A Campochiaro; Aleksander S Popel; Niranjan B Pandey
Journal:  JCI Insight       Date:  2019-02-21

Review 6.  Harnessing developmental processes for vascular engineering and regeneration.

Authors:  Kyung Min Park; Sharon Gerecht
Journal:  Development       Date:  2014-07       Impact factor: 6.868

Review 7.  Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference.

Authors:  Nikolett M Biel; Dietmar W Siemann
Journal:  Cancer Lett       Date:  2014-10-12       Impact factor: 8.679

Review 8.  The progress of angiogenic factors in the development of leukemias.

Authors:  Yang Han; Xidi Wang; Bingping Wang; Guosheng Jiang
Journal:  Intractable Rare Dis Res       Date:  2016-02

Review 9.  Therapeutic targeting of the angiopoietin-TIE pathway.

Authors:  Pipsa Saharinen; Lauri Eklund; Kari Alitalo
Journal:  Nat Rev Drug Discov       Date:  2017-05-19       Impact factor: 84.694

10.  Tuning the specificity of a Two-in-One Fab against three angiogenic antigens by fully utilizing the information of deep mutational scanning.

Authors:  Patrick Koenig; Sarah Sanowar; Chingwei V Lee; Germaine Fuh
Journal:  MAbs       Date:  2017-06-06       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.